The Effect of Potassium Bicarbonate on Bone and Several Physiological Systems During Immobilisation
NUC
1 other identifier
interventional
8
1 country
1
Brief Summary
Mainly due to the absence of gravitational forces in weightlessness, astronauts suffer from an increased bone loss- negatively affecting health and vitality during a mission. The development of effective countermeasures to this loss includes many different aspects like sports but also nutrition. Alkaline salts, abundant in fruits and vegetables, have shown to have positive effects on markers of bone turnover of postmenopausal women but also men and younger adults. With the current study the effects of a potassium bicarbonate supplementation added to a standardised, strictly controlled, definite diet of healthy, young men, should be verified within 21 days of 6°- HDT- Bedrest- the gold standard of simulating weightlessness within earthbound conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2010
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2010
CompletedFirst Submitted
Initial submission to the registry
July 4, 2011
CompletedFirst Posted
Study publicly available on registry
January 13, 2012
CompletedMarch 1, 2017
February 1, 2017
8 months
July 4, 2011
February 28, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The reduction of the immobilisation induced bone loss by supplementing an alkaline salt (potassium bicarbonate)
21 days of HDT- Bedrest
Secondary Outcomes (6)
Influence of KHCO3 on bone mass, bone mineral density and bone strength
21 days of HDT- Bedrest
Determination of effects of KHCO3 on muscle strength, muscle power and muscle volume
21 days of HDT- Bedrest
Determine the effects of KHCO3 on body composition and body weight
21 days of HDT- Bedrest
Determine the effects of KHCO3 on the cardiovascular system
21 days of HDT- Bedrest
Determine the effects of KHCO3 on the neuro- vestibular system
21 days of HDT- Bedrest
- +1 more secondary outcomes
Study Arms (2)
Potassium Bicarbonate
ACTIVE COMPARATORControl
NO INTERVENTIONInterventions
90 mmol daily, effervescent tablets 30 mmol diluted in 200 ml tab water supplemented three times a day together with the main meals for 21 days of HDT- bedrest
Eligibility Criteria
You may qualify if:
- healthy male subjects
- age: 20- 45
- weight 65- 85 kg
- height: 158- 190 cm
- BMI 20- 26 kg/m2
- no high performance sports
- non- smoking (minimum 6 months prior to study start)
- willing to complete both parts of the study
- presentation of social security and criminal record
- successful completion of medical and psychological screening
- signed informed consent
You may not qualify if:
- drugs- and alcohol abuse
- antiinflammatory drugs taken during the study
- vegetarianism, veganism
- migraine
- psychical illness in the past
- claustrophobia
- hiatal hernia
- gastroesophageal reflux
- diabetes mellitus
- Rheumatic disease
- muscle or joint disease
- disc prolapse
- orthostatic intolerance
- Hyperlipidaemia
- renal disease
- +14 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- DLR German Aerospace Centerlead
- University of Triestecollaborator
- University of Aarhuscollaborator
- European Space Agencycollaborator
Study Sites (1)
German Aerospace Centre (DLR)
Cologne, 51147, Germany
Related Publications (1)
Frings-Meuthen P, Bernhardt G, Buehlmeier J, Baecker N, May F, Heer M. The negative effect of unloading exceeds the bone-sparing effect of alkaline supplementation: a bed rest study. Osteoporos Int. 2019 Feb;30(2):431-439. doi: 10.1007/s00198-018-4703-6. Epub 2018 Sep 25.
PMID: 30255228DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Francisca May, Dr.
German Aerospace Centre, Institute of Aerospace Medicine (DLR)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 4, 2011
First Posted
January 13, 2012
Study Start
February 1, 2010
Primary Completion
October 1, 2010
Study Completion
October 1, 2010
Last Updated
March 1, 2017
Record last verified: 2017-02